Kurs & Likviditet
Kalender
| 2024-11-07 | Kvartalsrapport 2024-Q3 |
| 2024-08-15 | Kvartalsrapport 2024-Q2 |
| 2024-05-16 | Kvartalsrapport 2024-Q1 |
| 2024-03-21 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2024-03-20 | Årsstämma |
| 2024-02-27 | Bokslutskommuniké 2023 |
| 2023-11-09 | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | Kvartalsrapport 2023-Q2 |
| 2023-05-11 | Kvartalsrapport 2023-Q1 |
| 2023-03-30 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2023-03-29 | Årsstämma |
| 2023-03-02 | Bokslutskommuniké 2022 |
| 2022-11-10 | Kvartalsrapport 2022-Q3 |
| 2022-08-11 | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | Kvartalsrapport 2022-Q1 |
| 2022-05-09 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2022-04-06 | Årsstämma |
| 2022-03-10 | Bokslutskommuniké 2021 |
| 2021-11-11 | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | Kvartalsrapport 2021-Q1 |
| 2021-04-16 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2021-04-15 | Årsstämma |
| 2021-03-11 | Bokslutskommuniké 2020 |
| 2020-11-12 | Kvartalsrapport 2020-Q3 |
| 2020-08-13 | Kvartalsrapport 2020-Q2 |
| 2020-05-14 | Kvartalsrapport 2020-Q1 |
| 2020-04-03 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2020-04-02 | Årsstämma |
| 2020-03-12 | Bokslutskommuniké 2019 |
| 2019-11-14 | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | Kvartalsrapport 2019-Q2 |
| 2019-05-16 | Kvartalsrapport 2019-Q1 |
| 2019-04-05 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2019-04-04 | Årsstämma |
| 2019-03-07 | Bokslutskommuniké 2018 |
| 2018-11-15 | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | Kvartalsrapport 2018-Q2 |
| 2018-05-16 | Kvartalsrapport 2018-Q1 |
| 2018-04-20 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2018-04-19 | Årsstämma |
| 2018-03-07 | Bokslutskommuniké 2017 |
| 2017-11-08 | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | Kvartalsrapport 2017-Q2 |
| 2017-05-17 | Kvartalsrapport 2017-Q1 |
| 2017-04-06 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2017-04-05 | Årsstämma |
| 2017-03-15 | Bokslutskommuniké 2016 |
| 2016-11-09 | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | Kvartalsrapport 2016-Q2 |
| 2016-05-18 | Kvartalsrapport 2016-Q1 |
| 2016-04-20 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2016-04-19 | Årsstämma |
| 2016-03-16 | Bokslutskommuniké 2015 |
| 2015-11-05 | Kvartalsrapport 2015-Q3 |
| 2015-08-28 | Kvartalsrapport 2015-Q2 |
| 2015-05-22 | Kvartalsrapport 2015-Q1 |
| 2015-04-22 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2015-04-21 | Årsstämma |
| 2015-03-12 | Bokslutskommuniké 2014 |
| 2014-11-07 | Kvartalsrapport 2014-Q3 |
| 2014-08-21 | Kvartalsrapport 2014-Q2 |
| 2014-05-06 | Kapitalmarknadsdag 2014 |
| 2014-04-29 | Kvartalsrapport 2014-Q1 |
| 2014-04-29 | Årsstämma |
| 2014-03-21 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2014-03-20 | Bokslutskommuniké 2013 |
| 2013-11-15 | Kvartalsrapport 2013-Q3 |
| 2013-08-29 | Kvartalsrapport 2013-Q2 |
| 2013-05-15 | Kvartalsrapport 2013-Q1 |
| 2013-04-30 | Årsstämma |
| 2013-04-30 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2013-03-14 | Bokslutskommuniké 2012 |
| 2012-11-29 | Kapitalmarknadsdag 2012 |
| 2012-04-26 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2012-04-25 | Årsstämma |
| 2011-11-17 | Kvartalsrapport 2011-Q3 |
| 2011-10-25 | Kapitalmarknadsdag 2011 |
| 2011-08-18 | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | Kvartalsrapport 2011-Q1 |
| 2011-04-29 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
| 2011-04-28 | Årsstämma |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Company announcement – No. 17 / 2020
Zealand Pharma to participate in upcoming investor conferences
Copenhagen, DK and Boston, MA, U.S. March 25, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the following investor conferences in April:
| Guggenheim Virtual Healthcare Talks - Genomic Medicines & Rare Disease |
| Date: Thursday, April 1, 2021 |
| 20th Annual Virtual Needham Healthcare Conference |
| Date: Monday, April 12, 2021 |
| Presentation: 11:45 a.m. ET/ 4:45 p.m. CET |
A live webcast of the Needham event will be available on the "Events & Presentations" page in the Investor section of the Company's website at https://www.zealandpharma.com/events-presentations. A replay of the webcast will be archived on the Company's website following the presentation.
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development, and commercialization of next generation peptide-based medicines that change the lives of people living with metabolic and gastrointestinal diseases. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s robust pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand markets V-Go®, an all-in-one basal-bolus insulin delivery option for people with diabetes. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics. Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA). For more information about Zealand’s business and activities, please visit http://www.zealandpharma.com.
For further information, please contact:
Zealand Pharma Investor Relations
Claudia Styslinger
Argot Partners
investors@zealandpharma.com
Zealand Pharma Media Relations
David Rosen
Argot Partners
media@zealandpharma.com